AllianceBernstein
BTAI icon

AllianceBernstein’s BioXcel Therapeutics BTAI Stock Holding History

AllianceBernstein’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,874
Closed -$84.6K – 3245
2024
Q1 		$84.6K Hold
1,874
– – ﹤0.01% 3040
2023
Q4 		$88.5K Sell
1,874
-369
-16% -$20.5K ﹤0.01% 3078
2023
Q3 		$90.8K Hold
2,243
– – ﹤0.01% 3083
2023
Q2 		$239K Buy
2,243
+743
+50% +$247K ﹤0.01% 2937
2023
Q1 		$448K Hold
1,500
– – ﹤0.01% 2617
2022
Q4 		$516K Buy
1,500
+144
+11% +$34.8K ﹤0.01% 2615
2022
Q3 		$256K Hold
1,356
– – ﹤0.01% 2929
2022
Q2 		$286K Sell
1,356
-1,230
-48% -$259K ﹤0.01% 2897
2022
Q1 		$865K Sell
2,586
-91,712
-97% -$26.6M ﹤0.01% 2477
2021
Q4 		$30.7M Buy
94,298
+30,532
+48% +$13.1M 0.01% 790
2021
Q3 		$31M Buy
63,766
+4,812
+8% +$2.12M 0.01% 776
2021
Q2 		$27.4M Buy
58,954
+7,961
+16% +$4.34M 0.01% 811
2021
Q1 		$35.2M Buy
50,993
+8,155
+19% +$6.56M 0.02% 722
2020
Q4 		$31.7M Buy
42,838
+5,945
+16% +$4.63M 0.01% 725
2020
Q3 		$25.6M Buy
36,893
+5,368
+17% +$4.03M 0.01% 731
2020
Q2 		$26.7M Buy
31,525
+30,756
+3,999% +$20.1M 0.02% 675
2020
Q1 		$275K Buy
+769
New +$276K ﹤0.01% 2661

Other funds holding BTAI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AllianceBernstein's BTAI Position: Q2 2024 in Review

AllianceBernstein sold out of BioXcel Therapeutics (BTAI) in Q2 2024, closing a stake of 1,874 shares — an estimated $84.6K sold.

AllianceBernstein first reported a position in BTAI in Q1 2020 and held it in 17 quarters. The position peaked at $35.2M in Q1 2021. 74 funds tracked by Wall St. Rank hold BTAI as of Q2 2024.

  • AllianceBernstein reported no remaining BioXcel Therapeutics position as of Q2 2024 after selling out during the quarter.
  • AllianceBernstein sold 1,874 BioXcel Therapeutics shares in Q2 2024, an estimated $84.6K.
  • AllianceBernstein first reported a position in BioXcel Therapeutics in Q1 2020 and held it in 17 quarters.
  • AllianceBernstein's BioXcel Therapeutics position peaked at $35.2M in Q1 2021.
  • 74 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q2 2024.

Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.